Compare CSTE & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSTE | CCEL |
|---|---|---|
| Founded | 1987 | 1989 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Building Materials | Managed Health Care |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.7M | 32.7M |
| IPO Year | 2012 | 2022 |
| Metric | CSTE | CCEL |
|---|---|---|
| Price | $1.10 | $3.17 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 9.9K |
| Earning Date | 03-04-2026 | 04-14-2026 |
| Dividend Yield | N/A | ★ 4.70% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $25,384,279.00 |
| Revenue This Year | $3.43 | N/A |
| Revenue Next Year | $2.83 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 9.76 |
| 52 Week Low | $0.56 | $2.87 |
| 52 Week High | $3.26 | $6.79 |
| Indicator | CSTE | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 47.19 | 46.76 |
| Support Level | $0.86 | $3.13 |
| Resistance Level | $2.00 | $3.57 |
| Average True Range (ATR) | 0.18 | 0.10 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 60.27 | 67.78 |
Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.